Do Other Medications Impact Vascepa's Effectiveness?
Vascepa, a prescription omega-3 fatty acid medication, is used to treat high triglycerides. Aspirin is a commonly used over-the-counter pain reliever and anti-inflammatory medication. Research on the interaction between aspirin and Vascepa is limited [1].
How Does Aspirin Affect Vascepa?
Studies on the impact of aspirin on Vascepa's effectiveness are inconclusive. A study published in the Journal of Clinical Lipidology found that taking aspirin and Vascepa together did not significantly affect triglyceride levels [2]. Another study suggested that aspirin may decrease Vascepa's triglyceride-lowering effect, but the difference was not statistically significant [3].
What Should Patients Do?
Patients taking Vascepa who also take aspirin should consult their doctor to discuss potential interactions and determine the best course of treatment. While the scientific evidence is limited, it is essential to prioritize patient safety and efficacy.
Who Makes Vascepa?
Vascepa (icosapent ethyl) is manufactured by Amarin, a pharmaceutical company specializing in cardiovascular and metabolic health products.
When Does Patent Exclusivity Expire?
The Vascepa patent expires in 2030, which may allow generic versions to enter the market [4].
Sources:
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416543/
[2] https://www.jclp.org/article/S1933-2874(18)30243-7/fulltext
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291115/
[4] DrugPatentWatch.com